[Use of cystostatic agents in diffuse glomerulonephritis]. 1976

L D Zhdanova, and B B Bondarenko, and V I Shishkin

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

L D Zhdanova, and B B Bondarenko, and V I Shishkin
May 1977, Klinicheskaia meditsina,
L D Zhdanova, and B B Bondarenko, and V I Shishkin
May 1973, Terapevticheskii arkhiv,
L D Zhdanova, and B B Bondarenko, and V I Shishkin
August 1971, Meditsinskaia sestra,
L D Zhdanova, and B B Bondarenko, and V I Shishkin
June 1967, Wiener klinische Wochenschrift,
L D Zhdanova, and B B Bondarenko, and V I Shishkin
July 1966, Terapevticheskii arkhiv,
L D Zhdanova, and B B Bondarenko, and V I Shishkin
May 1963, La Semana medica,
L D Zhdanova, and B B Bondarenko, and V I Shishkin
May 1971, Meditsinskaia sestra,
L D Zhdanova, and B B Bondarenko, and V I Shishkin
March 1973, Munca sanitara,
L D Zhdanova, and B B Bondarenko, and V I Shishkin
April 1971, Meditsinskaia sestra,
L D Zhdanova, and B B Bondarenko, and V I Shishkin
August 1985, Fel'dsher i akusherka,
Copied contents to your clipboard!